NS
Therapeutic Areas
Oxurion Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Next-Gen Therapies | Geographic Atrophy (GA) / Age-related Macular Degeneration (AMD) | Unspecified |
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Next-Gen Therapies | Geographic Atrophy (GA) / Age-related Macular Degeneration (AMD) | Unspecified |